A Phase 4 interventional study of Propofol Injection in Propofol Adverse Reaction and Anesthesia, sponsored by Hospital Central de la Defensa Gómez Ulla. Completed at 1 site in Spain. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-08-12.
Sponsored by Hospital Central de la Defensa Gómez Ulla · Phase 4, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Objective: Determine if, by reducing the dose of propofol and increasing the time elapsed between fentanyl and propofol administration, hemodynamic response is improved.
Methods: Patients were randomized into time groups (2 and 1 minute) and each subdivided into dose groups (1, 1.5 and 2 mg kg-1) obtaining six time-dose groups. After receiving 2 μg kg-1 of fentanyl, propofol was administered after the predetermined time. Time to hypnosis (BIS\<60) and hemodynamic parameters at pre-induction, pre-intubation and postintubation were registered.
A minimum of 162 patients were required, considering an expected Mean Difference of 5 with expected Standard Deviation of 22, confidence level of 95% and power of 80%. Estimating a possible loss of 15%, it was raised to 192. Consecutive identification numbers were assigned and the sample was randomized in six groups of 32 patients according to time and dose of propofol.
Pre-oxygenation was performed until the expired oxygen fraction exceeded 80% and 2 µg/kg of intravenous fentanyl were administered. Depending on the study group, 1 or 2 minutes were allowed to pass and 1, 1.5 or 2 mg/kg of propofol were supplied (prior administration of intravenous lidocaine 0.5 mg/kg). The time in which the BIS dropped below 60 was recorded. If it did not reach that level after two minutes or when it exceeded it but then rose above 60 again, an extra dose of propofol of 0.5 mg/kg was administered. Muscle relaxation was performed with rocuronium 0.6 mg/kg. The patient was manually ventilated until endotracheal intubation was performed by the same experienced anaesthesiologist and connected to mechanical ventilation.
Data were collected manually. Statistical analysis was performed using SPSS ver. 22. Inferential statistics were performed using t-test for quantitative variables, chi-square for qualitative and ANOVA for qualitative and quantitative comparisons. Non-parametric statistical tests were used when necessary. Confidence intervals were estimated at a level of 95% and a P value of \<.05 was considered statistically significant.
Hospital Central de la Defensa Gómez Ulla is the lead sponsor of 4 studies on the registry; 1 is open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
2 mcg/kg of fentanyl administrated intravenously. wait for 2 minutes to inject 2 mg/kg of propofol
Drug: Propofol Injection
2 mcg/kg of fentanyl administrated intravenously. wait for 2 minutes to inject 1,5 mg/kg of propofol
Drug: Propofol Injection
2 mcg/kg of fentanyl administrated intravenously. wait for 2 minutes to inject 1 mg/kg of propofol
Drug: Propofol Injection
2 mcg/kg of fentanyl administrated intravenously. wait for 1 minute to inject 2 mg/kg of propofol
Drug: Propofol Injection
2 mcg/kg of fentanyl administrated intravenously. wait for 1 minute to inject 1,5 mg/kg of propofol
Drug: Propofol Injection
2 mcg/kg of fentanyl administrated intravenously. wait for 1 minute to inject 1 mg/kg of propofol
Drug: Propofol Injection
1, 1.5 or 2 mg/kg of propofol according to the subgroup
Systolic Blood Pressure Variation
Non-invasive systolic blood pressure change (%) at baseline, pre-intubation and postintubation. Positive results mean percentage reduction in SBP between the studied moments. Negative results mean percentage increase in SBP between the studied moments.
Time frame: Baseline before fentanyl administration, pre-intubation after propofol and bispectral index<60 and postintubation 15 seconds after endotracheal tube positioned
Heart Rate Variation
Heart rate change (%) registered at baseline, pre-intubation and postintubation. Positive results mean percentage reduction in HR between the studied moments. Negative results mean percentage increase in HR between the studied moments.
Time frame: Baseline before fentanyl administration, pre-intubation after propofol and bispectral index<60 and postintubation 15 seconds after endotracheal tube positioned
Systolic Blood Pressure Variation in Elderly (>55y)
Non-invasive SBP change (%) in patients \> 55 years at baseline, pre-intubation and postintubation. Positive results mean percentage reduction in SBP between the studied moments. Negative results mean percentage increase in SBP between the studied moments.
Time frame: Baseline before fentanyl administration, pre-intubation after propofol and bispectral index<60 and postintubation 15 seconds after endotracheal tube positioned
Time to Hypnosis
Bispectral index (BIS)\<60 meaning "general anesthesia", BIS\>60 meaning mild/moderate sedation. We measure the time until patient reachs hypnosis
Time frame: After administration of propofol, time is measured in seconds until BIS values are less than 60
Number of Patients Who Needed Vasoactive Drug
Patients who suffered SPB reduction \> 30% or SPB \< 90mmHg, receive vasoactive drugs
Time frame: 1 minute after intubation
Every patient who agreed to participate and required general anesthesia with endotracheal intubation by the same anesthesiologist
| Milestone | 2 Minute - 2 mg/kg Group | 2 Minute - 1,5 mg/kg Group | 2 Minutes - 1 mg/kg Group | 1 Minute - 2 mg/kg Group | 1 Minute - 1,5 mg/kg Group | 1 Minute - 1 mg/kg Group |
|---|---|---|---|---|---|---|
| Started | 32 | 32 | 32 | 32 | 32 | 32 |
| Completed | 31 | 30 | 31 | 31 | 32 | 31 |
| Not completed | 1 | 2 | 1 | 1 | 0 | 1 |
| Withdrew: Physician decision | 1 | 1 | 1 | 1 | 0 | 1 |
| Withdrew: Monitorization problem | 0 | 1 | 0 | 0 | 0 | 0 |
Non-invasive systolic blood pressure change (%) at baseline, pre-intubation and postintubation. Positive results mean percentage reduction in SBP between the studied moments. Negative results mean percentage increase in SBP between the studied moments.
| percentage of variation | 2 Minute - 2 mg/kg Group | 2 Minute - 1,5 mg/kg Group | 2 Minute - 1 mg/kg Group | 1 Minute - 2 mg/kg Group | 1 Minute - 1,5 mg/kg Group | 1 Minute - 1 mg/kg Group |
|---|---|---|---|---|---|---|
| SBP baseline/pre-intubation | 26 ± 16 | 23 ± 12 | 18 ± 13 | 22 ± 11 | 18 ± 13 | 17 ± 13 |
| SBP baseline/postintubation | 11 ± 22 | 8 ± 15 | 9 ± 19 | 14 ± 18 | 16 ± 19 | 8 ± 16 |
| SBP pre-intubation/postintubation | -22 ± 27 | -21 ± 28 | -12 ± 17 | -12 ± 21 | -3 ± 16 | -12 ± 16 |
Heart rate change (%) registered at baseline, pre-intubation and postintubation. Positive results mean percentage reduction in HR between the studied moments. Negative results mean percentage increase in HR between the studied moments.
| percentage of variation | 2 Minute - 2 mg/kg Group | 2 Minute - 1,5 mg/kg Group | 2 Minute - 1 mg/kg Group | 1 Minute - 2 mg/kg Group | 1 Minute - 1,5 mg/kg Group | 1 Minute - 1 mg/kg Group |
|---|---|---|---|---|---|---|
| HR baseline/pre-intubation | 6 ± 13 | 4 ± 8 | 4 ± 10 | 1 ± 11 | 4 ± 15 | 5 ± 14 |
| HR baseline/postintubation | -10 ± 19 | -8 ± 15 | -9 ± 16 | -4 ± 17 | -5 ± 20 | -10 ± 18 |
| HR pre-intubation/postintubation | -17 ± 19 | -12 ± 16 | -15 ± 20 | -5 ± 16 | -10 ± 19 | -17 ± 19 |
Non-invasive SBP change (%) in patients \> 55 years at baseline, pre-intubation and postintubation. Positive results mean percentage reduction in SBP between the studied moments. Negative results mean percentage increase in SBP between the studied moments.
| percentage of variation | 2 Minute - 2 mg/kg Group | 2 Minute - 1,5 mg/kg Group | 2 Minute - 1 mg/kg Group | 1 Minute - 2 mg/kg Group | 1 Minute - 1,5 mg/kg Group | 1 Minute - 1 mg/kg Group |
|---|---|---|---|---|---|---|
| SBP baseline/pre-intubation | 36 ± 12 | 26 ± 12 | 21 ± 13 | 29 ± 6 | 21 ± 13 | 22 ± 13 |
| SBP baseline/postintubation | 19 ± 22 | 10 ± 14 | 13 ± 19 | 22 ± 15 | 22 ± 17 | 12 ± 13 |
| SBP pre-intubation/postintubation | -27 ± 32 | -23 ± 30 | -10 ± 16 | -10 ± 23 | 2 ± 13 | -15 ± 19 |
Bispectral index (BIS)\<60 meaning "general anesthesia", BIS\>60 meaning mild/moderate sedation. We measure the time until patient reachs hypnosis
| seconds | 2 Minute - 2 mg/kg Group | 2 Minute - 1,5 mg/kg Group | 2 Minute - 1 mg/kg Group | 1 Minute - 2 mg/kg Group | 1 Minute - 1,5 mg/kg Group | 1 Minute - 1 mg/kg Group |
|---|---|---|---|---|---|---|
| Time to Hypnosis | 54 ± 29 | 49 ± 27 | 62 ± 34 | 41 ± 20 | 47 ± 15 | 67 ± 42 |
Patients who suffered SPB reduction \> 30% or SPB \< 90mmHg, receive vasoactive drugs
| Participants | 2 Minute - 2 mg/kg Group | 2 Minute - 1,5 mg/kg Group | 2 Minute - 1 mg/kg Group | 1 Minute - 2 mg/kg Group | 1 Minute - 1,5 mg/kg Group | 1 Minute - 1 mg/kg Group |
|---|---|---|---|---|---|---|
| Number of Patients Who Needed Vasoactive Drug | 4 | 1 | 0 | 2 | 3 | 0 |
Collected over Baseline until 60 seconds after endotracheal tube positioned. Non-serious events are listed at a 1% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| 2 Minute - 2 mg/kg Group | 0/31 (0%) | 0/31 (0%) | 4/31 (12.9%) |
| 2 Minute - 1,5 mg/kg Group | 0/30 (0%) | 0/30 (0%) | 1/30 (3.3%) |
| 2 Minute - 1 mg/kg Group | 0/31 (0%) | 0/31 (0%) | 0/31 (0%) |
| 1 Minute - 2 mg/kg Group | 0/31 (0%) | 0/31 (0%) | 2/31 (6.5%) |
| 1 Minute - 1,5 mg/kg Group | 0/32 (0%) | 0/32 (0%) | 3/32 (9.4%) |
| 1 Minute - 1 mg/kg Group | 0/31 (0%) | 0/31 (0%) | 0/31 (0%) |
| Event | 2 Minute - 2 mg/kg Group | 2 Minute - 1,5 mg/kg Group | 2 Minute - 1 mg/kg Group | 1 Minute - 2 mg/kg Group | 1 Minute - 1,5 mg/kg Group | 1 Minute - 1 mg/kg Group |
|---|---|---|---|---|---|---|
| Vasoactive drug needCardiac disorders | 4/31 | 1/30 | 0/31 | 2/31 | 3/32 | 0/31 |
| Age, Continuous(years) | 2 Minute - 2 mg/kg Group | 2 Minute - 1,5 mg/kg Group | 2 Minute - 1 mg/kg Group | 1 Minute - 2 mg/kg Group | 1 Minute - 1,5 mg/kg Group | 1 Minute - 1 mg/kg Group | Total |
|---|---|---|---|---|---|---|---|
| Mean | 59 ± 20 | 61 ± 17 | 60 ± 19 | 59 ± 17 | 64 ± 18 | 55 ± 16 | 60 ± 18 |
| Sex: Female, Male(Participants) | 2 Minute - 2 mg/kg Group | 2 Minute - 1,5 mg/kg Group | 2 Minute - 1 mg/kg Group | 1 Minute - 2 mg/kg Group | 1 Minute - 1,5 mg/kg Group | 1 Minute - 1 mg/kg Group | Total |
|---|---|---|---|---|---|---|---|
| Female | 15 | 14 | 17 | 17 | 18 | 14 | 95 |
| Male | 16 | 16 | 14 | 14 | 14 | 17 | 91 |
| Race and Ethnicity Not Collected(Participants) | 2 Minute - 2 mg/kg Group | 2 Minute - 1,5 mg/kg Group | 2 Minute - 1 mg/kg Group | 1 Minute - 2 mg/kg Group | 1 Minute - 1,5 mg/kg Group | 1 Minute - 1 mg/kg Group | Total |
|---|---|---|---|---|---|---|---|
| Count of participants | — | — | — | — | — | — | 0 |
| weight(kilograms) | 2 Minute - 2 mg/kg Group | 2 Minute - 1,5 mg/kg Group | 2 Minute - 1 mg/kg Group | 1 Minute - 2 mg/kg Group | 1 Minute - 1,5 mg/kg Group | 1 Minute - 1 mg/kg Group | Total |
|---|---|---|---|---|---|---|---|
| Mean | 73 ± 16 | 77 ± 17 | 70 ± 15 | 71 ± 15 | 71 ± 15 | 73 ± 15 | 72 ± 15 |
| anesthesia risk (ASA), categorical(Participants) | 2 Minute - 2 mg/kg Group | 2 Minute - 1,5 mg/kg Group | 2 Minute - 1 mg/kg Group | 1 Minute - 2 mg/kg Group | 1 Minute - 1,5 mg/kg Group | 1 Minute - 1 mg/kg Group | Total |
|---|---|---|---|---|---|---|---|
| Low risk | 20 | 19 | 17 | 21 | 13 | 21 | 111 |
| High risk | 11 | 11 | 14 | 10 | 19 | 10 | 75 |
| Hypertension(Participants) | 2 Minute - 2 mg/kg Group | 2 Minute - 1,5 mg/kg Group | 2 Minute - 1 mg/kg Group | 1 Minute - 2 mg/kg Group | 1 Minute - 1,5 mg/kg Group | 1 Minute - 1 mg/kg Group | Total |
|---|---|---|---|---|---|---|---|
| Count of participants | 15 | 9 | 15 | 13 | 16 | 13 | 81 |
| Antihypertensive treatment(Participants) | 2 Minute - 2 mg/kg Group | 2 Minute - 1,5 mg/kg Group | 2 Minute - 1 mg/kg Group | 1 Minute - 2 mg/kg Group | 1 Minute - 1,5 mg/kg Group | 1 Minute - 1 mg/kg Group | Total |
|---|---|---|---|---|---|---|---|
| Count of participants | 9 | 9 | 12 | 10 | 12 | 11 | 63 |
| Heart rate treatment(Participants) | 2 Minute - 2 mg/kg Group | 2 Minute - 1,5 mg/kg Group | 2 Minute - 1 mg/kg Group | 1 Minute - 2 mg/kg Group | 1 Minute - 1,5 mg/kg Group | 1 Minute - 1 mg/kg Group | Total |
|---|---|---|---|---|---|---|---|
| Count of participants | 11 | 7 | 10 | 9 | 11 | 3 | 51 |
PDFs hosted by the registry, ClinicalTrials.gov.
Plan to share: No
Ran from Nov 2017 to primary completion in Oct 2018, 11 months.
Results were first posted in Aug 2020, 1 year 9 months after primary completion.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Aug 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Propofol
Hospital Central de la Defensa Gómez Ulla